CLINICAL_TRIALS
trial_result
· 2016-04-11
Clinical Trial Update: Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial evaluating the safety and efficacy of dapagliflozin as part of triple therapy for type 2 diabetes, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2016-04-11